Daily Derm Times: September 2, 2025

To stay up-to-date with the latest dermatology news, sign up to receive our eNewsletters.

Adherence Challenges Take Center Stage in Psoriasis Management

Experts in Miami Beach emphasized that adherence often drives biologic choice more than efficacy in real-world psoriasis care.

Replimune Prepares for Type A Meeting With FDA on RP1

The FDA cited concerns about patient population heterogeneity and confirmatory trial design.

Almirall and Absci Expand Collaboration to Accelerate AI-Powered Drug Discovery for Skin Diseases

Almirall and Absci enhance their collaboration, leveraging AI to revolutionize drug discovery for challenging dermatological conditions and improve patient outcomes.

Stepwise Care in Chronic Spontaneous Urticaria

Explore effective strategies for managing CSU, including tailored therapies and the latest treatment advancements for optimal patient care.

Beyond Bad Habits: Understanding and Treating Dermatillomania and Trichotillomania

Sofia Wenzler, PhD, addresses misconceptions about dermatillomania (skin picking) and trichotillomania (hair pulling), advocating for compassionate care and accessible treatment for BFRBs.

Selective JAK Inhibition With Deuruxolitinib Restores Hair Growth in Alopecia Areata

Vimal Prajapati, MD, FRCPC, DABD, reviews the mechanism of action, clinical trial outcomes, monitoring considerations, and safety profile of recently available deuruxolitinib.